Sublingual administration of tacrolimus in a renal transplant patient

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 1, 2008, Pages 87-89

  Romero, I ^a   Jimenez C ^a   Gil, F ^a   Escuin, F ^a   Ramirez, E ^a   Fudio, S ^a   Borobia, A ^b   Carcas, A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Hospital Universitario La Paz ^*

Author keywords

Renal transplantation; Sublingual administration; Tacrolimus

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; DIGESTIVE SYSTEM HEMORRHAGE; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; GRAFT REJECTION; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; TREATMENT FAILURE;

ADMINISTRATION, SUBLINGUAL; BIOLOGICAL AVAILABILITY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; TACROLIMUS;

EID: 38349018463     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00884.x     Document Type: Article

References (11)

1. Takamatsu Y, Ishizu M, Ichinose I 2001) Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogenic bone marrow transplant recipient. Bone Marrow Transplantation, 28, 421 423.
2. Hodak S, Moubarak J, Rodriguez A 1998) QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. Transplantation, 66, 535 537.
3. Prograf FDA (2006) Technical Data of Tacrolimus. http://www.fda.gov/ medwatch/safety/2006/Mar%20PIs/Prograf_PI.pdf.
4. Staatz CE, Tett SE 2005) Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging, 22, 541 557.
5. Staatz CE, Tett SE 2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clinical Pharmacokinetics, 43, 623 653.
6. Barry D, Kahan E, Keown P 2002) Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clinical Therapeutics, 24, 330 350.
7. Scott LJ, McKeage K, Keam SJ, Plosker GL (2003) Tacrolimus: a further update of its use in the management of organ transplantation. Drugs, 63, 1247 1297.
8. Venkataramanan R, Swaminathan A, Prasad T 1995) Clinical pharmacokinetics of tacrolimus. Clinicial Pharmacokinetics, 29, 404 430.
9. Goorhuis JF, Scheenstra R, Peeters PM, Alberts MJ 2006) Bucal vs. nasogastric tube administration of tacrolimus after pediatric liver transplantation. Pediatric Transplantation, 10, 74 77.
10. Reams D, Rea T, Davis D 2001) Utility of sublingual tacrolimus in cystic fibrosis patients after lung transplantation. Journal of Heart Lung Transplantation, 20, 207 208.
11. Reams D, Palmer SM (2002) Sublingual tacrolimus for inmunosupression in lung transplantation. A potentially important therapeutic option in cystic fibrosis. American Journal of Respiratory Medicine, 1, 91 98.